the melanocortinbased peptide pt141 PT-141 (Bremelanotide) PT-141 Nasal Spray (Bremelanotide) 40mg,

with and without diastase), and Alcian blue at pH 2.5

Below are coding guidelines in a tabulated format: How to use this table: The (*) mark specifies the nature of the condition

Made clinically

Conversely, many histologically dysplastic naevi appear clinically banal (eg, small and uniform in colour and structure)

Groups More Likely to Experience Nausea Clinical data indicate that nausea is more common in: First-time PT-141 users Patients receiving higher initial doses Premenopausal women treated for hypoactive sexual desire disorder (HSDD) Those with prior medication sensitivity or a history of motion sickness Additional caution is warranted in patients with cardiovascular disease due to the medications potential effects on blood pressure